Hüpofüüsi ja hüpotaalamuse hormoonid ja nende analoogid (H01), süsteemse kasutusega kortikosteroidid (H02)

Integrity Indicators

3 out of 4

Has multiple bidders
No disputes from bidders or outsiders
Sellers have not recently made any political party donations
Bidding period is associated with an increased risk factor

Estimated Cost

Actual Cost

€1.06M

Duration

32 days

Bidders

4 bidders

Bids

4 bids

Disputes

0 disputes

Process Type	Open procedure
Offers Revealed At	Jan 3, 2020 9:02am

Showing board-level people associated with the buyer and seller organizations 12 months prior up to 12 months after the procurement process. Also shown are their political affiliations and donations within the same period.

Contracts

First Pharma OÜ 1. Läänemaa Haigla Signed Feb 26, 2020 with completion deadline Feb 25, 2022.	€366 est. €366
First Pharma OÜ 2. Raplamaa Haigla Signed Feb 25, 2020 with completion deadline Feb 24, 2022.	€122 est. €122
First Pharma OÜ 3. PERH Signed Feb 17, 2020 with completion deadline Feb 16, 2022.	€12,200 est. €12,200
MAGNUM MEDICAL OÜ 4. PERH (Magnum) Signed Feb 17, 2020 with completion deadline Feb 16, 2022.	€1.04M est. €1.04M
MAGNUM MEDICAL OÜ 6. Läänemaa Haigla (Magnum) Signed Feb 26, 2020 with completion deadline Feb 25, 2022.	€1,965^.14 est. €1,965^.14
MAGNUM MEDICAL OÜ 7. Raplamaa Haigla (Magnum) Signed Feb 25, 2020 with completion deadline Feb 24, 2022.	€1,401^.59 est. €1,401^.59

Integrity Indicators

Estimated Cost

Actual Cost

Duration

Bidders

Bids

Disputes

Contracts

First Pharma OÜ

First Pharma OÜ

First Pharma OÜ

MAGNUM MEDICAL OÜ

MAGNUM MEDICAL OÜ

MAGNUM MEDICAL OÜ